CYP17A1 and obesity disorder: These findings suggest that CYP17A1 may play a role in the pathophysiology of obesity, and that decreased expression of CYP17A1—potentially leading to reduced levels of 17α-OHPreg—may be associated with obesity and postoperative weight loss outcomes.